National trends in the treatment of attention deficit hyperactivity disorder.

  title={National trends in the treatment of attention deficit hyperactivity disorder.},
  author={Mark Olfson and Marc J. Gameroff and Steven C. Marcus and Peter S. Jensen},
  journal={The American journal of psychiatry},
  volume={160 6},
OBJECTIVE Nationally representative descriptive data were presented regarding recent trends in the outpatient treatment of attention deficit hyperactivity disorder (ADHD) in children. METHOD Service use data were analyzed in children ages 3 to 18 years from two nationally representative surveys of the U.S. general population, the 1987 National Medical Expenditure Survey, and the 1997 Medical Expenditure Panel Survey. Trends in the rates of treatment for ADHD were presented by age, gender… 

Tables from this paper

Trends in recognition of and service use for attention-deficit hyperactivity disorder in Britain, 1999-2004.
It is suggested that attention-deficit hyperactivity disorder (ADHD) is underdiagnosed in Britain and that parental factors determine service use, and barriers to care for ADHD appear to have been reduced in recent years.
Prevalence, recognition, and treatment of attention-deficit/hyperactivity disorder in a national sample of US children.
Poor children are most likely to meet criteria for ADHD yet are least likely to receive consistent pharmacotherapy, and the wealthiest children were more likely than the poorest to receive regular medication treatment.
National Estimates and Factors Associated With Medication Treatment for Childhood Attention-Deficit/Hyperactivity Disorder
Current medication treatment among youth with attention-deficit/hyperactivity disorder was associated with white race, younger age, English spoken in the home, health care coverage, a health care contact within the last year, and reported psychological difficulties.
Prevalence of Attention Deficit Hyperactivity Disorder and Associated Features Among Children in France
The epidemiology of ADHD in French children is similar to the epidemiology in other countries, and the well-known association of ADHD with CD, ODD, and indices of school failure is replicated.
Medication use and spending trends among children with ADHD in Florida's Medicaid program, 1996-2005.
The use of antipsychotics as a second-tier agent in treating ADHD has overtaken traditional agents such as antidepressants or alpha agonists, suggesting a need for research into the efficacy and side effects of second-generation antipsychotic among children with ADHD.
National variation of ADHD diagnostic prevalence and medication use: health care providers and education policies.
To better understand the association between a state's health care provider characteristics and both diagnostic prevalence and medication use, it may be fruitful to examine the content of provider continuing education programs, including the recommendations of major health professional organization guidelines to treat ADHD.
Prevalence of Parent-Reported ADHD Diagnosis and Associated Treatment Among U.S. Children and Adolescents, 2016
There is a large population of U.S. children and adolescents who have been diagnosed with ADHD by a health care provider, and many, but not all, of these children received treatment that appears to be consistent with professional guidelines, though the survey questions are limited in detail about specific treatment types received.
Under-Diagnosis of Attention Deficit Hyperactivity Disorder in One ofNon-western Country-Taiwan
Policy maker in Taiwan should design more educational program to improve the early recognition of child and adolescent with ADHD and under-diagnosis of ADHD is an urgent child mental problem in one of Non-western country.
ADHD medication use in a population-based sample of twins.
OBJECTIVE To determine treatment patterns for youth attention-deficit/hyperactivity disorder (ADHD) symptoms in a general population sample of 1,610 twins. METHOD Twin pairs ages 7 to 17 years and
Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.
Using data from the 1997-2000 Medical Expenditure Panel Survey (MEPS), disparities in different stages of attention-deficit/hyperactivity disorder (ADHD) health care were investigated, from initial


Treatment services for children with ADHD: a national perspective.
Significant shifts have occurred in stimulant prescriptions since 1989, with prescriptions now comprising three fourths of all visits to physicians by children with ADHD and diagnostic services increased 3-fold between 1989 and 1996.
Comparison of diagnostic criteria for attention-deficit hyperactivity disorder in a county-wide sample.
DSM-IV criteria are likely to increase the prevalence of this disorder in comparison with DSM-III-R rates, but they may better characterize its heterogeneity, as well as identify five factors: opposition/defiance-conduct, inattention, hyperactivity/impulsivity, anxiety/depression, and stealing-truancy.
Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
  • P. JensenL. Kettle J. Payne
  • Psychology, Medicine
    Journal of the American Academy of Child and Adolescent Psychiatry
  • 1999
Medication treatments are often not used in treating ADHD children identified in the community, suggesting the need for better education of parents, physicians, and mental health professionals about the effectiveness of these treatments.
Stimulant treatment for children: a community perspective.
In this area of the Great Smoky Mountains, stimulant treatment was being used in ways substantially inconsistent with current diagnostic guidelines.
Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
National survey estimates in the 1990s confirm the substantial increase in visits for youths diagnosed as having ADHD, with more than three quarters of these visits associated with psychotherapeutic medication treatment.
Stimulant treatment in Maryland public schools.
This large, population-based, point prevalence study of medication administered to students for ADHD adds new and updated findings on prevalence variations, rates for minority and special education/Section 504 students, and specialty prescriber rates.
Medication Management of Stimulants in Pediatric Practice Settings: A National Perspective
Investigation of the management practices of pediatricians, psychiatrists, and family practice physicians found that these practices diverge from National Institutes of Health (NIH) consensus panel recommendations and association‐issued practice parameters.
Behavioral versus Behavioral and Pharmacological Treatment in ADHD Children Attending a Summer Treatment Program
Comparisons to normative data revealed that Comb children were more likely to fall within the normative range on 6 measures, and the differences between these results and the main MTA results, in which Comb was always superior to Beh are discussed in terms of the relative intensity of combined treatments.
A meta-analysis of clonidine for symptoms of attention-deficit hyperactivity disorder.
Clonidine may be an effective second-tier treatment for symptoms of ADHD, but it has an effect size less than that of stimulants.
Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): Implications and Applications for Primary Care Providers
Primary analyses revealed that Comb had a significant incremental effect over MedMgt (with a small effect size for this comparison) when categorical indicators of excellent response and when composite outcome measures were used.